Clinical Trial Update: Prospective, Randomized Study for Predicting Human Cytomegalovirus (hCMV) Infection Based on Baseline hCMV Specific T-cell Response in Kidney Transplant [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating whether baseline CMV-specific T-cell responses can predict CMV infection in kidney transplant recipients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cmv Infection
• Kidney Transplantation

Snippet

Sponsor: ORIOL BESTARD | Conditions: CMV Infection, Kidney Transplantation | Phase 4 | Status: COMPLETED